BRAIN Biotech AG (ETR:BNN)

Germany flag Germany · Delayed Price · Currency is EUR
2.340
-0.020 (-0.85%)
Mar 6, 2026, 5:35 PM CET
-4.49%
Market Cap 51.12M
Revenue (ttm) 49.01M
Net Income (ttm) -10.62M
Shares Out 21.85M
EPS (ttm) -0.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 113
Average Volume 6,893
Open 2.360
Previous Close 2.360
Day's Range 2.340 - 2.360
52-Week Range 1.805 - 3.890
Beta 0.64
RSI 48.61
Earnings Date Feb 25, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio... [Read more]

Sector Materials
Founded 1993
Employees 292
Stock Exchange Deutsche Börse Xetra
Ticker Symbol BNN
Full Company Profile

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.

Financial Statements

News

There is no news available yet.